Literature DB >> 11243607

Treatment of carcinoma of the parotid gland: the results of a multicenter study.

A Tullio1, C Marchetti, E Sesenna, R Brusati, R Cocchi, V Eusebi.   

Abstract

PURPOSE: This study analyzed the prognostic factors for carcinoma of the parotid gland and the role of surgery alone or with radiotherapy in treating these lesions.
METHODS: Forty-five patients with malignant parotid tumors were studied retrospectively. Patients were treated by combined surgery and radiation therapy between 1984 and 1995 at the Maxillo-Facial Departments of the General Hospitals of Bologna and Parma. Resection was conservative when possible, depending on the extent of the tumor. The median follow-up time was 54 months. Data regarding incidence, tumor stage and grade, local control, distant metastases (calculated with the Kaplan-Meier method), and survival were analyzed. Cox's multiple linear regression was used to identify patient and tumor characteristics with the greatest prognostic significance.
RESULTS: The actuarial 5- and 8-year disease-free survival rates were 81% and 62%, respectively. Multivariate analysis showed that tumor stage was a more prognostic variable than tumor grade. Residual microscopic disease at the excision margins was also an important prognostic variable. Laterocervical metastases affected 4 patients (9%), and distant metastases appeared in 8 patients (18%).
CONCLUSIONS: Postoperative irradiation is indicated for patients with stage III and IV disease, patients with positive excision margins, and for patients with lymph node metastases.

Entities:  

Mesh:

Year:  2001        PMID: 11243607     DOI: 10.1053/joms.2001.20986

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  7 in total

1.  Parotid carcinoma: Current diagnostic workup and treatment.

Authors:  Vincent L M Vander Poorten; Francis Marchal; Sandra Nuyts; Paul M J Clement
Journal:  Indian J Surg Oncol       Date:  2010-11-21

2.  [Treatment of salivary gland malignancies].

Authors:  Michael Formanek
Journal:  Wien Med Wochenschr       Date:  2008

3.  BCL-2, p53 and HLA-DR antigen expression in surgically treated parotid cancer patients.

Authors:  Michael Genetzakis; Ilias P Gomatos; Anastasia N Georgiou; John Giotakis; Leonidas Manolopoulos; Kappaonstantina Papadimitriou; Helen Chra; Emmanuel Leandros; Christos Tsigris; Eleutherios A Ferekidis
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-06-27       Impact factor: 2.503

4.  Are all prognostic factors in parotid gland carcinoma well recognized?

Authors:  Dominik Stodulski; Boguslaw Mikaszewski; Czeslaw Stankiewicz
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-08-06       Impact factor: 2.503

5.  Extracapsular extension is not a significant prognostic indicator in non-squamous cancers of the major salivary glands.

Authors:  Shayan Cheraghlou; Phoebe K Yu; Michael D Otremba; Saral Mehra; Wendell G Yarbrough; Benjamin L Judson
Journal:  Cancers Head Neck       Date:  2018-07-03

Review 6.  Imaging of salivary gland tumours.

Authors:  Harriet C Thoeny
Journal:  Cancer Imaging       Date:  2007-04-30       Impact factor: 3.909

7.  Clinicopathologic factors associated with recurrence in parotid carcinoma.

Authors:  Dong Hoon Lee; Tae Mi Yoon; Joon Kyoo Lee; Sang Chul Lim
Journal:  Braz J Otorhinolaryngol       Date:  2017-08-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.